ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lineus Medical Signs Distribution Agreement with Clinical Technology, Covering the Midwest United States

By: PRLog

FAYETTEVILLE, Ark. - March 17, 2022 - PRLog -- Lineus Medical signed on its fifth distributor in as many months as it continues to expand its distribution network with the addition of Clinical Technology, a specialty distributor of medical products based out of Brecksville, OH. The Clinical Technology sales team services the mid-western region, covering Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. The group employs 14 vascular access sales representatives covering this geographic territory.

"With the addition of Clinical Technology, we now have sales representation across the entire United States, and we are excited to have them as part of the team," Vance Clement, CEO of Lineus Medical stated. "Clinical Technology has a large sales force dedicated to the sales and promotion of vascular access products with unmatched, proven track record in their territory. We are excited to have them on board as a strategic partner."

"Clinical Technology has provided innovative medical devices to hospitals since 1978," said Kent Krafft, Vice President at Clinical Technology. "Our sales force is excited about introducing SafeBreak Vascular to our customers and helping them realize the time savings and cost savings that can be achieved with this product."

SafeBreak Vascular is a break-away connector that fits into any peripheral IV line in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.

SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other  medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.

1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015

MKG-0131 Rev 00

Photos: (Click photo to enlarge)

Lineus Medical Logo Clinical Tech Logo Lineus Medical Logo Safebreak On Patient Arm

Read Full Story - Lineus Medical Signs Distribution Agreement with Clinical Technology, Covering the Midwest United States | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.